2 terminated, 1 not yet recruiting, 1 unknown. 2 Phase 3, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 1, Unknown 1 |
| Not applicable | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Terminated 1 |
Follow Steroid eye drops: new trials by email Literature Review of Steroid eye drops trials Research Report on Steroid eye drops
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis Steroid eye drops, Tacrolimus eye drops - Vernal Keratoconjunctivitis | Not applicable | Not yet recruiting | Sohag University | 90 | 2025-09-01 | 2025-08-24 |
| Steroid Eye Drops in Chronic Central Serous Chorioretinopathy steroid eye drops, Placebo - Chronic Central Serous Chorioretinopathy | Phase 3 | Unknown | Radboud University Medical Center | 40 | 2023-02-19 | 2024-04-11 |
| Economic Impact of Dropless Therapy Versus Usual Care for Cataract Surgery: A Real-World Study. Dropless Therapy, Usual Care - Cataract Surgery | Phase 4 | Terminated | PeriPharm | 80 | 2018-08-15 | 2021-09-21 |
| UNITE Study: Understanding New Interventions With GBM ThErapy Steroid eye drops, Vasoconstrictor eye drops, Cold compress - Glioblastoma Multiforme | Phase 3 | Terminated | AbbVie | 40 | 2018-07-30 | 2021-04-14 |
Conjunctivitis, Allergic (1) · Glioblastoma (1) · Neoplasms (1)
AbbVie (1) · PeriPharm (1) · Radboud University Medical Center (1) · Sohag University (1)
Netherlands (2) · Australia (1) · Canada (1) · Germany (1) · United Kingdom (1) · United States (1)
PMID 27050351, PMID 28803239, PMID 33144336
2017 (1)